Skip to content

Study · In vitro (cells) · rat · 1989

16 results

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.

Cheng K, Chan WW, Barreto A Jr, Convey EM, Smith RG

Endocrinology1 Jun 1989Cited by 168 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study16

14 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, GRF increased intracellular cAMP concentrations 3-fold.

    In plain wordsIn cells, GH-releasing factor raised cAMP, an internal signal molecule, 3-fold.

    Peptide
    Sermorelin
    Outcome
    IncreaseIntracellular cAMP after GRF
    Study

    ratn: not reported in source

    Rat primary pituitary cell culture
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Intracellular cAMP increase
    3-fold
    GRF

    Source sentences

    Summary
    GRF increased intracellular cAMP concentrations by 3-fold.
    1 context sentence
    Summary · context
    His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner.
  2. 02LabIn vitro (cells)Efficacy outcome

    In rat primary pituitary cells, GRF and GHRP-6 together at maximal concentrations produced a synergistic effect on GH release.

    In plain wordsIn cells, GH-releasing factor together with GHRP-6 released more growth hormone than expected from each alone.

    Peptide
    Sermorelin
    Outcome
    IncreaseGH release with GRF plus GHRP-6 at maximal concentrations
    Study

    ratn: not reported in source

    Rat primary pituitary cell culture
    Comparator
    Either peptide alone
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    When present together at maximal concentrations, GHRP-6 and GRF produced a synergistic effect on GH release.
    1 context sentence
    Summary · context
    His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner.
  3. 03LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, combined GRF and GHRP-6 potentiated the GRF-induced increase in cAMP levels.

    In plain wordsIn cells, adding GHRP-6 to GH-releasing factor increased the cAMP rise more than GH-releasing factor alone.

    Peptide
    Sermorelin
    Outcome
    IncreasecAMP with GRF plus GHRP-6
    Study

    ratn: not reported in source

    Rat primary pituitary cell culture
    Comparator
    GRF alone
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Combined treatment of pituitary cells with GRF and GHRP-6 resulted in a potentiation of the GRF-induced increase in cAMP levels.
    1 context sentence
    Summary · context
    His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner.
  4. 04LabIn vitro (cells)Efficacy outcome

    In rat primary pituitary cells, pretreatment with GRF for 1 h had no effect on the later GH release by GRF or GHRP-6.

    In plain wordsIn cells, one hour of earlier GH-releasing factor exposure did not change later growth hormone release by it or by GHRP-6.

    Peptide
    Sermorelin
    Outcome
    No significant changeResponse to GRF or GHRP-6 after 1 h GRF pretreatment
    Study

    ratn: not reported in source

    Rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated · 1 hAs given in this study (rat).

    Source sentences

    Summary
    In contrast, pretreatment with GRF for 1 h had no effect on the subsequent action of GHRP-6 or GRF on GH release.
    1 context sentence
    Summary · context
    His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner.
  5. 05LabIn vitro (cells)Activity measurement

    In rat primary pituitary cells, GHRP‑6 stimulated GH release in a time- and dose-dependent manner.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 stimulated growth hormone release, with more release at higher doses.

    Peptide
    GHRP-6
    Outcome
    IncreaseGH release
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) stimulated GH release from rat primary pituitary cells in a time- and dose-dependent manner.
  6. 06LabIn vitro (cells)Activity measurement

    In rat primary pituitary cells, half-maximal GH stimulation by GHRP‑6 needed 7 x 10(-9) M and maximal stimulation 10(-7) M.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 needed very low concentrations to stimulate growth hormone release.

    Peptide
    GHRP-6
    Outcome
    IncreaseConcentrations for half-maximal and maximal GH stimulation
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The concentrations of GHRP-6 required for half-maximal and maximal stimulation were 7 x 10(-9) and 10(-7) M, respectively.
  7. 07LabIn vitro (cells)Activity measurement

    In rat primary pituitary cells, GHRP‑6 stimulation of GH release was seen after 15 min but not after 4 h of incubation.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 stimulated growth hormone release after 15 minutes but not after 4 hours.

    Peptide
    GHRP-6
    Outcome
    No significant changeGH release after 4-h incubation
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated · 4 hAs given in this study (rat).

    Source sentences

    Summary
    Stimulation was observed after a 15-min, but not a 4-h, incubation.
  8. 08LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, GH release induced by GHRP‑6 was not affected by naloxone or the GRF antagonist.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 still released growth hormone when naloxone or a GRF blocker was added.

    Peptide
    GHRP-6
    Outcome
    No significant changeGHRP-6-induced GH release with naloxone or GRF antagonist
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    GH release induced by GHRP-6 was not affected by the addition of either naloxone or the GRF antagonist [N-Ac-Tyr1,D-Arg2]GRF-(1-29)-NH2.
  9. 09LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, GHRP‑6 had no effect on intracellular cAMP levels.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 did not change levels of the signal molecule cAMP.

    Peptide
    GHRP-6
    Outcome
    No significant changeIntracellular cAMP with GHRP-6 alone
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    GHRP-6 had no effect on intracellular cAMP levels, whereas GRF increased intracellular cAMP concentrations by 3-fold.
  10. 10LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, combined treatment with GRF and GHRP‑6 potentiated the GRF-induced increase in cAMP levels.

    In plain wordsIn rat pituitary cells in lab tests, adding GHRP‑6 made the cAMP rise caused by GRF larger.

    Peptide
    GHRP-6
    Outcome
    IncreaseGRF-induced cAMP with GHRP-6 added
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Comparator
    GRF alone
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Combined treatment of pituitary cells with GRF and GHRP-6 resulted in a potentiation of the GRF-induced increase in cAMP levels.
  11. 11LabIn vitro (cells)Activity measurement

    In rat primary pituitary cells, 1 h of pretreatment with GHRP‑6 reduced basal GH release by 30%.

    In plain wordsIn rat pituitary cells in lab tests, a 1-hour GHRP‑6 pretreatment lowered basal growth hormone release.

    Peptide
    GHRP-6
    Outcome
    DecreaseBasal GH release after 1-h GHRP-6 pretreatment
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    10(-7) M · 1 hAs given in this study (rat).

    Measurements

    Reduction in basal GH release
    30%
    after GHRP-6 pretreatment

    Source sentences

    Summary
    Basal GH release was reduced by 30% after pretreatment with GHRP-6 (10(-7) M) for 1 h.
  12. 12LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, GHRP‑6 pretreatment decreased the subsequent GH response to GHRP‑6.

    In plain wordsIn rat pituitary cells in lab tests, earlier GHRP‑6 exposure weakened the later growth hormone response to GHRP‑6.

    Peptide
    GHRP-6
    Outcome
    DecreaseSubsequent response to GHRP-6 after GHRP-6 pretreatment
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Pretreatment with GHRP-6 also decreased the subsequent response to GHRP-6
  13. 13LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, GHRP‑6 pretreatment did not decrease the subsequent GH response to GRF.

    In plain wordsIn rat pituitary cells in lab tests, earlier GHRP‑6 exposure did not weaken the later response to GRF.

    Peptide
    GHRP-6
    Outcome
    No significant changeSubsequent response to GRF after GHRP-6 pretreatment
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    but not GRF.
  14. 14LabIn vitro (cells)Mechanism

    In rat primary pituitary cells, desensitization induced by GHRP‑6 was completely reversed within 1 h after removal of the peptide.

    In plain wordsIn rat pituitary cells in lab tests, the weaker response after GHRP‑6 exposure fully recovered within an hour of removing it.

    Peptide
    GHRP-6
    Outcome
    Not applicableReversal of GHRP-6 desensitization
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The desensitization induced by GHRP-6 was completely reversed within 1 h after removal of the peptide.

Studies that did not test the peptide alone2

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 15LabNot a test of GHRP-6 aloneIn vitro (cells)Mechanism

    In rat primary pituitary cells, a GHRP‑6 analog inhibited GH release stimulated by GHRP‑6 without affecting GRF-induced release.

    In plain wordsIn rat pituitary cells in lab tests, a GHRP‑6 analog blocked growth hormone release caused by GHRP‑6 but not by GRF.

    Peptide
    GHRP-6
    Outcome
    DecreaseGHRP-6 analog inhibits GHRP-6-stimulated GH release
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH2, an analog of GHRP-6, inhibited GH release stimulated by GHRP-6 without affecting that induced by GRF.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  2. 16LabNot a test of GHRP-6 aloneIn vitro (cells)Activity measurement

    In rat primary pituitary cells, GHRP‑6 and GRF together at maximal concentrations produced a synergistic effect on GH release.

    In plain wordsIn rat pituitary cells in lab tests, GHRP‑6 and GRF together released more growth hormone than expected from each alone.

    Peptide
    GHRP-6
    Outcome
    IncreaseGH release with GHRP-6 plus GRF
    Study

    ratn: not reported in source

    rat primary pituitary cell culture
    Comparator
    GHRP-6 or GRF alone
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    When present together at maximal concentrations, GHRP-6 and GRF produced a synergistic effect on GH release.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 3 to 36Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 34 times, first on 9 Oct 2026, 19:08 UTC. The status did not change between them.

    Study results updated

  2. Version 2

    9 Oct 2026, 03:13 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.